Search Results for: stem cells for ms

Grading my 20 stem cell & regenerative medicine predictions for 2024

Stem cell, crystal ball, predictions

Did you predict the major events in the stem cell and regenerative medicine field this year? I tried and today’s post are the grades on my predictions. Prediction is a key part of being a scientist even if we may not think about it that much. For instance, we have to try to predict what

Grading my 20 stem cell & regenerative medicine predictions for 2024 Read More »

Weekly reads: intermittent fasting and stem cells, vet warning, blastemas

intermittent fasting and stem cells

Intermittent fasting must be good for stem cells, right? It’s not so clear. Like many things in biology, intermittent fasting can have seemingly opposite effects. Before we get into that, the news of the week is that the FDA approved Mesoblast’s Ryoncil MSC drug for some cases of pediatric GvHD. This has sparked lively discussion.

Weekly reads: intermittent fasting and stem cells, vet warning, blastemas Read More »

In landmark, FDA approves first MSC therapy, Mesoblast’s Ryoncil for GvHD

mesoblast ceo dr silvio itescu

In a landmark decision, today the FDA approved Ryoncil from Mesoblast for GvHD. This is the first time the FDA has approved a mescenchymal stromal/stem cell or MSC therapy of any kind. There have been many ups and downs for Mesoblast toward this approval of Ryoncil or remestemcel-L, an allogeneic marrow MSC product. See my

In landmark, FDA approves first MSC therapy, Mesoblast’s Ryoncil for GvHD Read More »

25 stem cell & regenerative medicine predictions for 2025

regenerative medicine, stem cell predictions

Toward the end of each year I make predictions for the stem cell and regenerative medicine field for the coming year. I’ve been doing this for more than a dozen years in various forms. In this post I’m looking at the (gene-edited, stemness enriched) tea leaves for 2025 for the regenerative arena. These predictions include

25 stem cell & regenerative medicine predictions for 2025 Read More »

Weekly stem cell reads: HSCT, old embryo models, aging stem cells

stem cell

What is a stem cell therapy? Does it have to include stem cells put into the body? Would you include a therapy that uses differentiated cells made from stem cells? I generally do use the term in that broader way. A similar question comes to mind: what is regenerative medicine? Should it include both cell

Weekly stem cell reads: HSCT, old embryo models, aging stem cells Read More »

Weekly reads: aging cells, scientists relying on ChatGPT, anemone stem cells

cellular aging

Do our aging cells necessitate that we age overall as people? Flipping it around, if we can stop or reverse enough cellular aging, will our overall aging be positively affected? It’s clear that people age very differently from each other and so do our cells and organs. Interestingly, intramurally in a sense the cells and

Weekly reads: aging cells, scientists relying on ChatGPT, anemone stem cells Read More »

Weekly reads: GIOSTAR stem cell clinic IND, cadaver marrow, NIH under Trump 2.0, tweets from a stem cell

Giostar

What happens if unproven stem cell clinic firms like GIOSTAR start getting okays from the FDA to do clinical trials? On the one hand, it could reflect a positive trend of stem cell clinic firms working with the FDA and toward compliance. Having more robust data. However, I worry about some of these types of

Weekly reads: GIOSTAR stem cell clinic IND, cadaver marrow, NIH under Trump 2.0, tweets from a stem cell Read More »

Cell Surgical Network asks whole court to weigh in after FDA appeals victory on stem cells

Cell Surgical Network stem cell clinic chain

It’s been a long saga for the FDA and the unproven stem cell clinic group called Cell Surgical Network, headquartered in Beverly Hills. A court case involving the two has been unfolding for many years. It has big implications for agency authority and the hundreds of stem cell clinics across the U.S. The case took

Cell Surgical Network asks whole court to weigh in after FDA appeals victory on stem cells Read More »